BioCool SPY-100 to SPY-10000 Biopharmaceutical Liquid Preparation System
| Brand | BioCool (BIOCOOL) |
|---|---|
| Origin | Beijing, China |
| Manufacturer Type | Authorized Distributor |
| Product Category | Domestic |
| Model | SPY-100–SPY-10000 |
| Pricing | Upon Request |
Overview
The BioCool SPY-100 to SPY-10000 Biopharmaceutical Liquid Preparation System is a fully integrated, GMP-compliant engineering solution designed for precise, repeatable, and traceable liquid formulation in biopharmaceutical manufacturing. Engineered for sterile process integrity, the system implements a closed-loop, hygienic fluid-handling architecture based on ASME BPE-2023 compliant design principles. It supports critical unit operations including buffer and media preparation, dilution, pH/condutivity adjustment, filtration, thermal conditioning (heating/cooling), and final sterile transfer. The system operates under validated process logic—governed by deterministic control sequences—and is structured around core hygienic modules: jacketed stainless-steel preparation vessels (316L electropolished), sanitary diaphragm pumps, steam-in-place (SIP) compatible valves and sensors, and single-use or reusable membrane filtration assemblies. Its operational foundation lies in continuous mass balance monitoring, real-time temperature-pressure-flow correlation, and dynamic setpoint tracking—ensuring compliance with pharmacopeial requirements for solution homogeneity, endotoxin control, and microbial limits.
Key Features
- GMP-aligned 3D modular architecture with ASME BPE-2023-compliant wetted surface finish (Ra ≤ 0.4 µm electropolished 316L stainless steel)
- Integrated CIP (Clean-in-Place) and SIP (Sterilize-in-Place) cycles with programmable flow velocity, temperature ramping, hold times, and conductivity-based endpoint detection
- Dual-mode thermal management: steam-heated jacket + glycol-cooled secondary loop, enabling ±0.5 °C temperature control across 5–85 °C operating range
- Automated gravimetric and volumetric dispensing with redundant load cell validation and Coriolis-based flow verification
- Full IEC 61511-compliant safety instrumented functions (SIFs), including overpressure protection, dry-run prevention, and SIP steam trap failure detection
- V-model lifecycle documentation per GAMP 5, covering URS, FDS, DQ/IQ/OQ/PQ protocols, and change control records
Sample Compatibility & Compliance
The SPY series accommodates a broad spectrum of biopharmaceutical liquids—including monoclonal antibody (mAb) formulation buffers, viral vector diluents, vaccine adjuvant suspensions, lyophilization preps, ophthalmic solutions, and parenteral nutrition admixtures. All wetted materials comply with USP Class VI, FDA 21 CFR Part 11, and ISO 13485:2016 requirements. System validation supports alignment with EU Annex 1 (2022), WHO TRS 986, and Chinese GMP Annex 1 (2023) for aseptic processing. Pressure vessel design conforms to PED 2014/68/EU and GB/T 150.1–2011. Surface bioburden reduction is verified per ISO 14644-1 Class 5 (ISO Class 5) during SIP cycle qualification.
Software & Data Management
Controlled by a validated Siemens SIMATIC PCS 7 DCS platform, the system delivers full audit trail functionality compliant with 21 CFR Part 11 and EU Annex 11. All process parameters—including weight, temperature, pressure, conductivity, pH, flow rate, valve position, and alarm status—are time-stamped, digitally signed, and stored in an encrypted SQL Server database with ≥15-year retention capability. Trend visualization includes overlayable batch comparison, deviation flagging, and automated PDF report generation (including electronic signatures). Data export supports CSV, PDF/A-2, and ASTM E2500-21 structured format for regulatory submission. Electronic batch records (EBRs) are synchronized with MES via OPC UA 1.04.
Applications
- Final formulation of therapeutic proteins and mAbs prior to ultrafiltration/diafiltration
- Preparation of cell culture media and harvest buffers for upstream bioprocessing
- Buffer exchange and dilution in downstream purification suites
- Manufacturing of sterile ophthalmic solutions under Grade A laminar airflow integration
- Support of clinical trial material (CTM) production with full traceability down to raw material lot level
- Integration with single-use bioreactor trains for end-to-end process continuity
FAQ
Does the SPY system support FDA 21 CFR Part 11-compliant electronic signatures?
Yes—the system implements role-based digital signature workflows with dual authentication, biometric optional integration, and immutable signature binding to each data record.
Can the SPY-10000 model be qualified for terminal sterilization of bulk drug substance?
No—it is designed for aseptic formulation and does not perform terminal sterilization; however, it supports SIP of all internal surfaces up to 135 °C for ≥30 minutes per EU Annex 1 requirements.
Is third-party validation support available for IQ/OQ/PQ execution?
Yes—BioCool provides vendor-qualified validation engineers and certified templates aligned with ISPE Baseline Guide Volume 5 and ASTM E2500-21.
What is the maximum allowable particulate count in the final dispensed solution?
Per USP , the system achieves ≤25 particles ≥10 µm and ≤3 particles ≥25 µm per mL when operated with qualified 0.22 µm sterilizing-grade filters and post-filtration hold conditions.
How is cleaning efficacy verified during CIP cycle development?
Via ATP bioluminescence assays, conductivity profiling, rinse water TOC analysis (<100 ppb), and visual inspection using borescope-integrated vessel mapping.
